Dietary intakes and biomarker patterns of folate, vitamin B6, and vitamin B12 can be associated with cognitive impairment by hypermethylation of redox-related genes NUDT15 and TXNRD1

Abstract

Background B vitamins in the one-carbon metabolism pathway (folate, vitamin B6, and vitamin B12) have been implicated in DNA methylation, and their deficiency may contribute to cognitive decline through increased homocysteine (Hcy) levels and subsequent oxidative damage. The aim of this study was to investigate whether B vitamin deficiency and increased Hcy could interact with DNA methylation of oxidative-related genes and exacerbate cognitive impairment. Methods Participants were selected from a large cohort study entitled the Effects and Mechanism Investigation of Cholesterol and Oxysterol on Alzheimer’s disease (EMCOA) study. We included 2533 participants who completed a selection of comprehensive cognitive tests and a semiquantitative food frequency questionnaire (FFQ) and were followed for an average of 2.3 years. The longitudinal effects of B vitamin intake on cognitive decline were examined using linear mixed-effect models. Seven mild cognitive impairment (MCI) patients, in the predementia stage of Alzheimer’s disease (AD), and fivev healthy controls were selected for the discovery of genome-wide differentially methylated CpG sites. Candidate oxidative stress-related genes significantly correlated with serum levels of B vitamins were selected for validation in 102 MCI patients and 68 controls. The correlations between DNA methylation levels and serum concentrations of B vitamins and oxidative biomarkers were analyzed with Spearman’s correlation. The interactive effects of DNA methylation and B vitamins on cognitive performance were further evaluated by multiple linear regression. Results In the prospective analysis, inadequate dietary intake of vitamin B12 was significantly associated with accelerated cognitive decline, whereas adequate folate, vitamin B6, and vitamin B12 intakes were significantly associated with better cognitive reserve. In the case-control analysis, the DNA methylation levels of NUDT15 and TXNRD1 were examined, and significantly hypermethylated sites were identified in MCI patients. Significant correlations of hypermethylated sites with serum levels of folate, homocysteine (Hcy), and oxidative biomarkers were observed, and interactive effects of B vitamins and hypermethylated sites were significantly associated with cognitive performance. Conclusion Adequate dietary folate at baseline predicted a better cognitive reserve, while decreased serum levels of B vitamins may contribute to cognitive impairment by affecting methylation levels of specific redox-related genes. Trial registration EMCOA, ChiCTR-OOC-17011882, Registered 5th, July 2017-Retrospectively registered, http://www.medresman.org/uc/project/projectedit.aspx?proj=2610 Graphical Abstract

Redox signaling and Alzheimer’s disease: from pathomechanism insights to biomarker discovery and therapy strategy

“…Although no clear mechanisms between B vitamin intake and cognitive decline have been well established, a series of biologically plausible mechanisms have been widely proposed to explain the effect of one-carbon metabolism relevant B vitamins, including vitamin B 12 , vitamin B 6 and folate on cognitive impairment [73]. Deficiencies in any of above-mentioned B vitamins may raise blood concentration of homocysteine via perturbing one-carbon metabolism and causing low enzymatic activities for homocysteine remethylation or trans-sulfuration, which contributes to oxidative damage and subsequent cognitive decline [74]. Hyperhomocysteinemia induced memory deficits with AD-like Aβ and tau pathologies in the hippocampus as well, while folate/ vitamin B 12 supplementation could improve memory by preventing hyperhomocysteinemia induced AD-like pathologies, highlighting B vitamins may be a preventive or even therapeutic alternative against AD [75].…”

Vitamins in Alzheimer’s Disease—Review of the Latest Reports

“…A cohort study by An et al, published in 2019 [ 23 ] involving 2533 participants with dementia or normal cognitive function, found that insufficient vitamin B12 intake contributed to cognitive decline, and adequate levels of folic acid, vitamin B6, and vitamin B12 had a beneficial effect on the cognitive resources of participants without cognitive impairment.…”

Epigenetics: Recent Advances and Its Role in the Treatment of Alzheimer's Disease

“…The treatment with alcohol extracts from G. lucidum increases methylation regulators and improves memory in APP/PS1 AD model mice (163). In AD and mild cognitive impairment patients, B vitamin intake results in hypermethylation of NUDT15 and TXNRD1, which is associated with better cognitive performance (164). The supplementation of folic acid, a methyl donor, improves cognitive functions in participants who tend to decline with age (165).…”